Hyperfine (HYPR) Other financing activities (2021 - 2026)
Hyperfine (HYPR) posted Other financing activities of $42000.0 for Q1 2026, up 61.54% on a QoQ basis from $26000.0 in Q4 2025, and up 27.27% year-over-year from $33000.0 in Q1 2025.
Hyperfine (HYPR) Other financing activities (2021 - 2026) Analysis & Trends
Hyperfine's Other financing activities history runs 6 years deep, the most recent figure standing at $42000.0 for Q1 2026.
- Quarterly Other financing activities rose 27.27% year-over-year to $42000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $165000.0 (up 10.74% YoY) and the FY2025 annual result came in at $156000.0, down 8.77% from the prior year.
- Other financing activities was $42000.0 for Q1 2026 at Hyperfine, up from $26000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $93000.0 in Q3 2025 and bottomed at $4000.0 in Q2 2025.
- A 5-year average of $39142.9 and a median of $40500.0 in 2023 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities surged 460.0% — and 2025, when it tumbled 93.22%.
- Hyperfine's Other financing activities stood at $5000.0 in 2022, then jumped by 460.0% to $28000.0 in 2023, then slumped by 60.71% to $11000.0 in 2024, then jumped by 136.36% to $26000.0 in 2025, then jumped by 61.54% to $42000.0 in 2026.
- Business Quant data shows HYPR's Other financing activities at $42000.0 in Q1 2026, $26000.0 in Q4 2025, and $93000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42,000.00 |
| Mar 31, 2026 | 42,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Mar 31, 2025 | 33,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Sep 30, 2024 | 46,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |